Shop by goal
Popular compounds
Research resources
Recently viewed
Where to Buy Retatrutide in the UK: A Research-Use Sourcing Guide
Short answer: retatrutide (LY3437943) is not licensed as a medicine in the UK - it is still in Phase 3 trials - so no UK pharmacy or clinic can legally supply it. In the UK it is available only from research-compound suppliers that label the material research use only , ship on a tracked UK service, and provide a per-batch Certificate of Analysis with HPLC purity and mass-spec identity. New-U Research Compounds ships retatrutide (catalogued as Retatrutide) to UK addresses on a tracked service, with free delivery over £300.
“Where can I buy retatrutide in the UK?” is one of the fastest-growing peptide search queries of 2026, driven by the published Phase 2 trial (Jastreboff et al., N Engl J Med 2023; PMID 37385275), in which investigators reported a mean change from baseline in body weight of −24.2% at week 48 in the 12 mg arm. Retatrutide has no marketing authorisation anywhere in the world , so it is not a prescription medicine and cannot be obtained from a UK pharmacy. This guide covers the laboratory and documentation criteria to apply when sourcing research material, and how the MHRA framing applies. For the wider legal picture, see our companion piece Are Peptides Legal in the UK?.
Plain-English summary. Retatrutide is an unapproved investigational compound with no marketing authorisation; it is not a licensed medicine in the UK. Material supplied on this basis is laboratory research material, not a medicine, and is not offered for human or veterinary use. Regulatory requirements vary by product, intended use and jurisdiction, and a research-use label does not by itself establish that a particular transaction or intended use complies with them — purchasers are responsible for confirming that. This page is general information, not legal or medical advice.
What retatrutide actually is
Retatrutide, developmental code LY3437943 , is a 39-amino acid synthetic peptide. Receptor-pharmacology studies characterise agonist activity at three receptors — GLP-1R, GIPR and GCGR — making it the first triple-receptor agonist of its class to reach late-stage clinical trials. The GCGR arm is what distinguishes it in the literature from single- and dual-agonist compounds; hepatic energy-expenditure endpoints are investigated alongside the incretin endpoints measured for the class as a whole.
For UK researchers comparing the incretin class, the line-up looks like this:
This is the key point UK buyers miss: retatrutide is a different regulatory category from Ozempic or Mounjaro . The first two are MHRA-licensed medicines. Retatrutide is not. That is why your GP cannot prescribe it, your local Boots or Lloyds cannot dispense it, and no UK private weight-loss clinic can supply it on a script. Regulatory requirements vary by product, intended use and jurisdiction; purchasers are responsible for ensuring that acquisition and use of research material complies with applicable requirements. For a side-by-side science explainer of the GLP-1 / GIP comparator class, see Semaglutide vs Tirzepatide; for where retatrutide sits in the broader regulatory map of approved-vs-investigational peptides, see Peptides & the FDA.
The MHRA position on retatrutide, precisely
The Medicines and Healthcare products Regulatory Agency (MHRA) regulates products presented for human or therapeutic use. A peptide marketed for people to take is treated as a medicine and must be licensed. A peptide supplied as a labelled research reagent - research use only, not for human consumption - is a separate, non-human-use category outside the MHRA medicines framework.
Because retatrutide has no marketing authorisation, the only thing the MHRA explicitly prohibits is selling or promoting it for human use . Possession of the molecule for genuine laboratory research is lawful. The legal line, exactly as for BPC-157 and the other research compounds covered in our UK legal explainer, is drawn at intended use and how the product is marketed , not at the molecule itself.
Why no UK pharmacy can sell you retatrutide
UK pharmacies and clinics can only dispense medicines that hold either a UK marketing authorisation or are imported under a named-patient / unlicensed-medicines special. Retatrutide has neither. Any UK-facing site claiming to sell “prescription retatrutide” or “clinic-grade retatrutide for weight loss” is either mis-selling a research compound under medical framing (which moves it into unlicensed-medicine territory the MHRA does prohibit), counterfeiting another GLP-1 product, or both. Treat any such offer as a red flag.
What a compliant UK retatrutide supplier looks like
The bar for a research-compound supplier is documentation, not marketing. A UK-facing supplier you can rely on for retatrutide should tick all of the following:
The absence of any single one of those is enough to walk away. The absence of a per-batch CoA is disqualifying full stop - without it you have no way to verify the molecule is actually retatrutide and not a relabelled cheaper peptide.
How New-U handles retatrutide for UK buyers
On our catalogue, retatrutide is listed as Retatrutide . Same 39-amino acid sequence, same triple-agonist mechanism, same molecule that Eli Lilly studies as LY3437943, supplied here as a research compound across our incretin range (semaglutide and retatrutide). This is the SEO line where UK searches for “retatrutide UK” and catalogue listings labelled Retatrutide meet.
How retatrutide is priced in the UK
Research-compound retatrutide is sold per vial or per sealed 10-vial pack, with pricing scaling by the milligrams of peptide per vial. As a rough orientation only, expect a range broadly comparable to other Phase-3 incretin research peptides at the same purity grade: lower-mg tiers (5–10 mg) at the entry of the range, mid-tier (15–30 mg) in the middle, and high-mg tiers (40–60 mg) at the top. UK visitors see GBP totals at the cart - not a USD price “converted at checkout” with a hidden margin baked in.
Anyone quoting you a price well below the prevailing market for verified >99%-pure peptide should set off alarm bells: either the purity isn’t there, the CoA isn’t real, or the molecule isn’t retatrutide. For why purity is the only number that matters, see how to read a CoA and our broader how to buy research peptides walkthrough.
UK delivery, customs and what to expect at the door
We dispatch UK orders on a tracked service with delivery typically inside the working week. The package is plain - no branding, no compound name on the outer label - and contains the sealed vials, a CoA reference card, and standard handling guidance. Because the contents are lyophilised research compound rather than a medicine, there is no controlled-drugs paperwork; the import is a normal scientific-reagent consignment.
Shipping is £25 flat tracked on UK orders, and free over £300 - which most retatrutide orders clear on the lowest tier. We absorb any minor handling fees up to the doorstep; on the rare occasion HMRC raises a query, we provide invoice and CoA documentation to support the research-reagent classification. See our UK delivery guide for the full breakdown.
Red flags to avoid on UK retatrutide searches
The combination of high search demand and no licensed product creates a predictable scam surface. Walk away from any UK-facing retatrutide listing that:
What you can’t buy in the UK, even from a research supplier
Worth saying plainly: New-U does not sell pre-mixed or ready-to-inject retatrutide, does not sell “weight-loss-grade” retatrutide, does not provide pens, autoinjectors or human dosing kits, and does not provide any clinical protocol or dosing schedule for retatrutide. The catalogue listing is lyophilised research peptide in a sealed glass vial, period. Anyone in the UK selling retatrutide pens or pre-mixed solutions is operating outside the research-use framing - which is exactly what the MHRA prohibits.
The bottom line for UK buyers
If you are searching for “where to buy retatrutide UK”, the honest map looks like this: retatrutide holds no marketing authorisation in Britain, so it is not a licensed medicine and no UK pharmacy can dispense it. Material supplied for laboratory research is not a medicine and is not offered for human or veterinary use. Regulatory requirements vary by product, intended use and jurisdiction; purchasers are responsible for ensuring that acquisition and use of research material complies with applicable requirements, and a research-use label does not by itself establish that a given transaction or intended use is compliant. Assess a supplier on its laboratory documentation — per-batch Certificate of Analysis, RP-HPLC purity, mass-spectrometry identity, a named testing laboratory, declared vial content, batch traceability and a verifiable trading entity — rather than on marketing copy. For anything health-related, consult a qualified clinician.
Frequently Asked Questions
Is retatrutide legal to buy in the UK? Retatrutide is not MHRA-licensed, so it is not a medicine in the UK and cannot be supplied or used as one. Material offered on a research basis is laboratory research material, not a medicine. Regulatory requirements vary by product, intended use and jurisdiction, and a research-use label does not by itself establish that a particular transaction or intended use complies with them - purchasers are responsible for confirming that.
Where can I buy retatrutide in the UK? No UK pharmacy or clinic can legally sell it. UK buyers source it from research-compound suppliers that ship to the UK, provide a per-batch CoA, and label material research use only. New-U ships retatrutide (catalogued as Retatrutide) on a tracked UK service.
How is retatrutide different from Ozempic or Mounjaro? Ozempic (semaglutide) is GLP-1 only. Mounjaro (tirzepatide) is dual GLP-1 / GIP. Retatrutide (LY3437943) is triple GLP-1 / GIP / glucagon, with the glucagon arm adding hepatic thermogenesis. Retatrutide is the only one of the three that is unlicensed.
How much does retatrutide cost in the UK? It is priced per vial in GBP, scaling by mg per vial across tiers from 5 mg to 60 mg. UK delivery is £35 tracked, free over £300.
How do I verify purity? Demand a per-batch Certificate of Analysis showing HPLC purity (>99% is the credible standard) and mass-spec identity, from a named third-party lab such as Janoshik or Freedom Diagnostics. New-U publishes both.
Related Reading
Primary sources & further reading
External links are provided for research reference only; New-U is not affiliated with these organisations and links carry no endorsement either way.
From the Lab - Peptides on LinkedIn & Facebook
Lab-Verified Retatrutide for UK Researchers
New-U Research Compounds ships retatrutide (catalogued as Retatrutide) to UK addresses in sealed 10-vial packs, independently verified by Janoshik and Freedom Diagnostics for >99% purity, with a per-batch Certificate of Analysis. Tracked UK delivery, free over £300. Research use only - all claims made on this site are for testing and research use only.
Research-grade · >99% HPLC purity · COA per lot
Buy Retatrutide from New-U Research Compounds
Lab-verified by Janoshik Analytical (RP-HPLC + ESI-MS), sealed vials, discreet tracked worldwide shipping. Research use only - all claims made on this site are for testing and research use only.
PRECISION. PURITY. PERFORMANCE.
Research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical & Freedom Diagnostics, with Certificates of Analysis published per released batch. Supplied strictly for laboratory research use.
Shop
Research
Support
Ways to Pay
Shop by goal
Shop by compound
Shop by region
Research use only - all claims made on this site are for testing and research use only. Purchasers must be 21 years of age or older.
All rights reserved. Copyright of New-U held with Hilxera Distribution Services LLC 2026.
Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.
© 2026 New-U Research Compounds · new-u.io